Most Viewed Chemotherapy Current Events | Chemotherapy News
|
| Page
1 of
25 |
498 Results |
|
|
|
Sort By:
Relevance | Date |
Yale procedure cuts recurrence of aggressive uterine cancer
A state-of-the-art treatment program developed at Yale School of Medicine increases survival from the aggressive uterine papillary serous carcinoma (UPSC) and spares some patients the need for additional therapy. view more (2005-09-22)
Low-dose chemotherapy plus antiangiogenesis drug has activity in advanced breast cancer
Chemotherapy given in low, frequent doses - a novel strategy called "metronomic" delivery - achieved partial shrinkage of disease in some advanced breast cancer patients when given concurrently with an angiogenesis inhibitor. view more (2005-12-09)
Thalidomide treatment proves better than conventional chemotherapy for multiple myeloma
When people hear "thalidomide," many think "birth defects," however, evidence has come to light that this once-banned drug can be used as a potent anti-cancer treatment. In a new study, researchers from the University of Bologna, Italy, demonstrate that Thal-Dex (thalidomide used in combination with dexamethasone) is more... view more... (2005-06-21)
Intraperitoneal chemotherapy administration prolongs survival for women with advanced ovarian cancer
A study featured in this month's edition of Gynecologic Oncology examines the challenges associated with the administration of intra-abdominal chemotherapy, also known as intraperitoneal (IP) chemotherapy. view more (2006-01-05)
Less extensive biopsy method helps diagnose cancer progression of large breast tumors
New breast cancer research shows for the first time that even women with large breast tumors can benefit from a less invasive biopsy method that has been reserved until now for women with small breast cancers. view more (2005-08-23)
Almost 1/3 of colon cancer patients stop chemotherapy, leading to double the death rate
New research from Columbia University Medical Center has found that as many as 30 percent of patients with stage III colon cancer who were prescribed six months of chemotherapy with a combination of 5-fluorouracil and leucovorin stopped their treatment prematurely. view more (2006-05-01)
Protein holds back growth of head and neck tumors
A protein associated with the growth of head and neck tumors may be a tumor suppressor that could prevent the spread of cancer when it is expressed above normal levels. view more (2006-02-01)
Specific treatments for each type of sarcoma
The new molecular techniques allow designing specific treatments for a great number of sarcomas, according to Dr. Enrique de Alava, expert of the department of Pathologic Anatomy of the University Clinic of the University of Navarre. The molecular knowledge has become a very useful tool to study several diseases. In particular, it provides... view more... (2002-11-29)
Rapid restoration of immunity in immune-suppressed cancer patients using T-cell vaccines
Patients with multiple myeloma suffer from a malignant proliferation of plasma cells in their bone marrow. view more (2005-10-21)
Chemotherapy after surgery extends survival for patients with advanced endometrial cancer
A new study has shown for the first time that giving two chemotherapy drugs to women with advanced endometrial cancer after surgery reduced the risk of recurrence by 29% and extended survival by 32% compared with women who received whole abdominal irradiation. view more (2005-12-06)
Gemcitabine and capecitabine improved overall survival in patients with advanced pancreatic cancer
The prognosis of pancreatic cancer is poor but new therapies such as gemcitabine have contributed to improving the outcome for patients. view more (2005-11-03)
Study finds novel vaccine curbs brain tumor growth, increases survival
A novel vaccine has significantly increased life expectancy in patients with glioblastoma multiforme (GBM), the most dangerous type of brain tumor. view more (2006-04-26)
National study improves outcome for pediatric AML
A new strategy for treating childhood acute myeloid leukemia (AML) based on the individual patient's risk of failure, and guided by the results of a highly sensitive technique for identifying leukemic cells, yielded one-year survival rates of almost 90 percent. view more (2005-12-14)
Ideal doses of IMRT defined to reduce treatment side effects for head and neck cancer
Results from a University of Pittsburgh study evaluating intensity modulated radiation therapy (IMRT) for head and neck cancer determined the ideal doses for lessening treatment side effects. view more (2005-10-19)
Stealth particles to target tumors
Stealth nano particles may some day target tumor cells and deliver medication to specific body locations, according to Penn State chemical engineers. view more (2005-09-01)
Treatment method improves survival for advanced laryngeal cancer, U-M study finds
Chemotherapy and radiation can be effective at treating cancer of the larynx, or voice box, without removing the organ that controls speech and swallowing. But it doesn't work for everyone. view more (2006-02-01)
Breast cancer drug receives FDA approval
A new use for the breast cancer drug Herceptin was approved by the FDA yesterday, a move that means more treatment options for the 25 percent of breast cancer patients with early-stage HER-2 positive breast cancer. view more (2006-11-20)
Positron Emission Tomography (PET) Can Identify Effectiveness of Chemotherapy Early in High-Risk Breast Cancer Patients
The effectiveness of chemotherapy in patients with advanced breast cancer can be evaluated earlier by using 18F-FDG positron emission tomography (PET) imaging over other conventional imaging procedures, according to an article in the July issue of the Society of Nuclear Medicine's Journal of Nuclear Medicine. view more (2005-07-27)
'Shuttling' protein possibly key to resilience of cancer cells
Researchers at Purdue University have discovered a molecular mechanism that may play a crucial role in cancer's ability to resist chemotherapy and radiation treatment and that also may be involved in Alzheimer's and heart disease. view more (2006-03-08)
Vitamin D, taxotere combination extends the lives of men with advanced prostate cancer
Men with advanced prostate cancer who take an experimental, high-dose vitamin D pill with chemotherapy live about eight months longer than those receiving chemotherapy and placebo. view more (2005-11-03)
|
|
| Page
1 of
25 |
498 Results |
|
|
|
Sort By:
Relevance | Date |
|
